WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Update

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the recipient of a significant decrease in short interest in September. As of September 30th, there was short interest totaling 20,600 shares, a decrease of 65.3% from the September 15th total of 59,400 shares. Based on an average daily trading volume, of 62,100 shares, the days-to-cover ratio is currently 0.3 days. Based on an average daily trading volume, of 62,100 shares, the days-to-cover ratio is currently 0.3 days.

Wall Street Analyst Weigh In

Separately, UBS Group raised shares of WuXi Biologics (Cayman) to a “buy” rating in a report on Thursday, August 7th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy”.

WuXi Biologics (Cayman) Stock Down 1.0%

Shares of WXXWY opened at $9.32 on Friday. The firm’s 50 day simple moving average is $9.31 and its 200 day simple moving average is $7.36. WuXi Biologics has a 1-year low of $3.60 and a 1-year high of $11.21.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC.